Atyr PHARMA (NASDAQ:ATYR) Coverage Initiated at Leerink Partners
Leerink Partners assumed coverage on shares of Atyr PHARMA (NASDAQ:ATYR – Get Free Report) in a research note issued to investors on Tuesday, Marketbeat.com reports. The brokerage set an “outperform” rating and a $16.00 price target on the stock. Leerink Partners’ price target suggests a potential upside of 276.47% from the stock’s current price. Several […]
Leerink Partners assumed coverage on shares of Atyr PHARMA (NASDAQ:ATYR – Get Free Report) in a research note issued to investors on Tuesday, Marketbeat.com reports. The brokerage set an “outperform” rating and a $16.00 price target on the stock. Leerink Partners’ price target suggests a potential upside of 276.47% from the stock’s current price. Several […]
